Trauma Devices | Market Insights | US | 2021
Compared to other major orthopedic device markets, the US trauma device market has been somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Nonetheless, the market has been affected by delays to nonurgent trauma cases and use of alternative treatments for less serious cases, restricting market expansion to some extent. Beyond the impact of the COVID-19 pandemic, the market will continue to be driven primarily by favorable demographics, improving reimbursement and site-of-service flexibility, improving physician training, and ongoing product innovation.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the United States across an 11-year period.
The COVID-19 pandemic has affected the trauma device market.
To what extent has COVID-19 impacted the US trauma device market?
How have procedure volumes in different segments of the market been affected by the crisis?
How quickly have procedure volumes recovered?
When will each segment of the market return to levels seen prior to the pandemic?
US trauma device procedure volume expansion will be driven by moderate growth in certain high-volume segments.
Which anatomic segments contribute most strongly to overall procedure volumes?
Which devices do physicians prefer using to treat these anatomies?
Which anatomic segments are seeing increased interest from competitors, and why?
How are procedural trends shifting due to improved technology and clinical data?
The reimbursement landscape for trauma procedures performed in the ASC setting remains in flux.
How has CMS site-of-service reimbursement changed in recent years? Which changes are ongoing?
How has the COVID-19 pandemic influenced site-of-service trends?
Which other value-based incentives and reimbursement model changes are impacting the US trauma device market?
Several manufacturers have recently expanded their product portfolios with the introduction of new devices or by acquiring companies with complementary products.
Which competitors are using the breadth of their product portfolios to sustain or increase their trauma device market shares?
How are competitors expanding their offerings through product innovation, mergers, acquisitions, and/or partnerships to capture a larger share of the trauma device market?
